Category Archives: Medical Devices

Wound Irrigation Devices Market to Register Substantial Expansion by 2027

The wound irrigation system is a flow of the solution used to an open wound surface to achieve the hydration of wound, to remove the debris and help in the visual examination of the wound. Wound irrigation is an important step in assisting the progression of wound healing from inflammatory phase to proliferative phase by removing the debris and surface pathogens. The goal of the wound irrigation is to clean the wound and avoid the trauma to wound bed to minimize the risk of bacterial and other contamination to the wound bed. Wound irrigation system also aids in healing the wound from the inside tissue layers outward to the surface of the skin and prevent premature healing of the wound. In wound irrigation system, the irrigation solutions such as topical cleansers, antibiotics, antifungal, antiseptics are used to remove the debris. The wound irrigation system is more effective as compared to swabbing or bathing of the wound and expected to boost the demand of the wound irrigation system over a forecast period.

Request Report TOC: https://www.futuremarketinsights.com/toc/rep-gb-3775

The global wound irrigation system market is anticipated to register a significant CAGR over a forecast period. The increasing use of convenient, user-friendly wound irrigation system over conventional wound cleaning techniques such as swabbing and bathing, is expected to boost the demand of the wound irrigation system and drives the global market. The wound irrigation system is more effective as it delivers the major advantage in emergency room acute wound management which also propels the demand of the wound irrigation system. The wound irrigation system also helps to prevent the spread of infection of bacteria and other pathogens due to the effective structure of the system, which anticipated to fuel the demand and growth of the global wound irrigation system market over a forecast period.

However, the lack of awareness about the benefits of the wound irrigation system over conventional methods of wound cleaning in poorly developed markets, may hamper the demand of the wound irrigation systems and restrain the growth of the global wound irrigation system market.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-3775

On the basis of regional presence, the global wound irrigation system market is segmented into seven key regions: North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific excluding Japan, Japan and Middle East & Africa. Currently, North America is contributing the leading shares to the global wound irrigation system market in terms of value and anticipated to register a significant CAGR over a forecast period. The Europe is also contributing the moderate shares to the market due to the advanced medical facilities and developed infrastructure along with the awareness of the wound irrigation system over conventional methods. APAC is the most lucrative market for the wound irrigation system and expected to show a robust growth to the global wound irrigation system market. MEA is at a nascent stage to the global wound irrigation system market and anticipated to register a decent growth to the market over a forecast period. Overall, the global wound irrigation system market is expected to show significant growth over a forecast period.

Some of the major market players in wound irrigation system market globally include Bionix Development Corporation, Molnlycke Health Care Ltd, Teleflex, Inc., IrriMax Corporation, Westmed, INC., CooperSurgical Inc., B. Braun Medical Inc., Centurion Medical Products Corporation and Zimmer, Inc.

Pre Book Wound Irrigation System Market Research Report: https://www.futuremarketinsights.com/checkout/3775

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

T (UK): +44(0)20-7692-8790

Sales: sales@futuremarketinsights.com

Website:  http://www.futuremarketinsights.com

Advertisements

Microfluidics Market Opportunity will Rise to US$ 11 Bn by 2026

Applications of microfluidics in drug delivery and diagnostics will continue to fuel the market for microfluidics over the next few years. “The US$ 2.9 Bn microfluidics market will possibly cross US$ 11 Bn by the end of 2026. North America is expected to contribute over US$ 3 Bn to the total revenues in 2026. The collective share of North America and Asia Pacific will be over 40%,” states Future Market Insights in a recently published market report outlook, titled “Microfluidics Market: Global Industry Analysis and Opportunity Assessment, 2016-2026.”

The global microfluidics market is segmented on the basis of material type, application, industry and region.

Based on material, ceramics will continue to be the most sought after material for microfluidic device or kit manufacturing. Ceramics segment is expected to remain dominance, accounting for over 42% market value share in 2026, followed by glass, polymer, and silicon. While ceramics is likely to witness the fastest growth, polymer segment is anticipated to exhibit a significant CAGR of over 15% over 2016-2026, driven by PVC.

By application, POCT (point of care testing) segment is projected to retain dominance through 2026, accounting for over 33% share in terms of revenues. Clinical diagnostics and analytical testing will remain the next major segments in the global microfluidics market.

On the basis of industry, in-vitro diagnostics, life science research, and pharmaceuticals are likely to be the key segments. In-vitro diagnostics segment is estimated to hold a share of over 35% in the total market revenues. The fastest growing segment will be in-vitro diagnosis.

Geographically, North America, followed by Western Europe are expected to remain the dominant regions for microfluidics, capturing respective market value share of over 26% and over 21% share by 2026 end. Asia Pacific (excluding Japan) will possibly represent the most lucrative market, expanding at a significant CAGR of over 14% throughout the forecast period.

Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-398

Summary of Table of Content:

1.Executive summary

2.Research Methodology

3.Assumptions and Acronyms Used

4.Global Microfluidics Market Overview

5.Global Microfluidics Market Dynamics

6.Global Microfluidics Market Trends

7.Global Microfluidics Market– Scenario Forecast

8.Global Microfluidics Market Value Chain Analysis

9.Global Microfluidics Market Price Projections per Region

10.Global Microfluidics Market Analysis by Material Type

11.Global Microfluidics Market Analysis by Application Type

12.Global Microfluidics Market Analysis by Industry

13.Global Microfluidics Market Analysis by Geography

14.North America Target Market Analysis and Forecast

15.Latin America Target Market Analysis and Forecast

16.Western Europe Market Analysis and Forecast

17.Eastern Europe Market Analysis and Forecast

18.APEJ Market Analysis and Forecast

19.Japan Market Analysis and Forecast

20.MEA Market Analysis and Forecast

21.Global Microfluidics Market: Competitive Landscape

Request to Browse Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/microfluidics-market/toc

Urinary Tract Infection Treatment Market to Attain a Value of US$ 11.58 Bn by 2026

The global Urinary tract infection treatment market was valued at US$ 9.2 Bn in 2015, and is projected to expand at a CAGR of 2.1% over forecast period 2016–2026, owing to increasing incidence of UTIs and recurring UTIs, increasing use of urinary catheters, and other drainage devices.

The global urinary tract infection treatment market is segmented on the basis of drug type, indication, distribution channel and region.

The global urinary tract infection treatment market is segmented into penicillin & combinations, quinolones, cephalosporin, aminoglycoside antibiotics, sulphonamides, azoles and amphotericin B, tetracycline, nitrofurans, and other segments.

By indication, the global urinary tract infection treatment market is segmented into complicated urinary tract infection, recurring complicated urinary tract infection, uncomplicated urinary tract infection, and neurogenic bladder infection. The neurogenic bladder infections indication segment is expected to expand at a CAGR of 2.6% in terms of revenue over the forecast period.

By distribution channel, the global urinary tract infection treatment market is segmented into hospital pharmacies, gynecology and urology clinics, drug store, retail pharmacies, and online drug stores. The online drug stores distribution channel segment is expected to expand at a CAGR of 2.8% in terms of revenues over the forecast period.

The global urinary tract infection treatment market has been segmented into seven major regions: North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding Japan (APEJ), and Japan and Middle East & Africa (MEA). Revenue from the North America market is expected to expand at a CAGR of 2.0% over the forecast period. In North America, the quinolones segment is expected to register a CAGR of 2.6% to reach value of US$ 695.4 Mn by 2026 end.

Request A Sample of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1340

Summary of Table of Content:

1.Assumptions and Acronyms Used

2.Research Methodology

3.Executive Summary

4.Urinary Tract Infection Treatment Market Overview

5.Global Urinary Tract Infection Treatment Market Analysis, By Drug Type

6.Global Urinary Tract Infection Treatment Market Analysis, By Distribution Channel

7.Global Urinary Tract Infection Treatment Market Analysis, By Indication

8.Global Urinary Tract Infection Treatment Market Analysis, By Region

9.North America Urinary Tract Infection Treatment Market Analysis

10. Latin America Urinary Tract Infection Treatment Market Analysis

11. Western Europe Urinary Tract Infection Treatment Market Analysis

12. Eastern Europe Urinary Tract Infection Treatment Market Analysis

14. Japan Urinary Tract Infection Treatment Market Analysis

15. MEA Urinary Tract Infection Treatment Market Analysis

16. Competition Landscape

Request to Browse Full Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/urinary-tract-infections-market/toc

About Us 

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us

616 Corporate Way, Suite 2-9018,

Valley Cottage, NY 10989,

United States

T: +1-347-918-3531

F: +1-845-579-5705

T (UK): +44(0)20-7692-8790

Sales: sales@futuremarketinsights.com

Website:  http://www.futuremarketinsights.com

Companion Animal Vaccines Market to Attain a Value of US$ 4,500 Mn by 2026

The global companion animal vaccines market was valued at more than US$ 2,100 Mn in 2015 and is projected to register a CAGR of 6.8% during the forecast period. The market is expected to be valued at nearly US$ 4,500 Mn by the end of 2026.

The Global Companion Animal Vaccines Market is segmented on the basis of species type, product type, distribution channel and region.

The Canine species segment is anticipated to register a 6.9% CAGR over the forecast period and be valued at nearly US$ 2,500 Mn by 2026 end.

Attenuated Live Vaccines will Continue to Witness Highest Demand. Nearly US$ 764 Mn worth of attenuated live vaccines were sold globally in 2016. This segment is projected to grow at a CAGR of 7.3% during the forecast period 2016-2026.

In 2016, these two distribution channels collectively accounted for nearly 75% revenue share of the market. By the end of forecast period, the status quo is expected to remain unchanged. Retail pharmacies, which held 20% share of the market in 2016, will grow at the highest CAGR during the forecast period.

The North America companion animals market was valued at nearly US$ 676 in 2016. It is projected to increase at 6.9% CAGR through 2026, reaching over US$ 1.3 Bn in revenues. Western Europe, the second-largest market for companion animal vaccines is projected to grow at 7.1% CAGR through 2026.

Request A Sample Request: https://www.futuremarketinsights.com/reports/sample/rep-gb-1427

Summary of Table of Content

1. Executive Summary

2. Market Introduction

3. Companion Animal Vaccines Market Analysis Scenario

4. Companion Animal Vaccines Market Dynamics

5. Global Companion Animal Vaccines Market Analysis and Forecast, By Product Type

6. Global Companion Animal Vaccines Market Analysis and Forecast, By Distribution Channel

7. Global Companion Animal Vaccines Market Analysis and Forecast, By Species Type

8. Global Companion Animal Vaccines Market Analysis and Forecast, By Region

9. North America Companion Animal Vaccines Market Analysis and Forecast

10. Latin America Companion Animal Vaccines Market Analysis and Forecast

11. Western Europe Companion Animal Vaccines Market Analysis and Forecast

12. Eastern Europe Companion Animal Vaccines Market Analysis and Forecast

13. Asia Pacific Excl. Japan (APEJ) Companion Animal Vaccines Market Analysis and Forecast

14. Japan Companion Animal Vaccines Market Analysis and Forecast

15. MEA Companion Animal Vaccines Market Analysis and Forecast

16. Competition Landscape

17. Assumptions and Acronyms Used

18. Research Methodology

Request to Browse Full Table of Content, figure and Tables @ https://www.futuremarketinsights.com/reports/companion-animal-vaccines-market/toc

Outpatient Clinics Market to Attain a Value of US$ 39,000 Mn by 2027

Growing advancements in medical technology has led to development of treatment techniques and medications that do not require the patients to stay for long hours at the clinics or hospitals. However, imposition of strict regulations will continue to hinder the global market growth of outpatient disorders over the forecast period. Future Market Insights states that the global market of outpatient clinics is projected to reflect a CAGR of 4.3%, representing more than US$ 39,000 Mn by 2022-end.

Read Report Preview: https://www.futuremarketinsights.com/reports/outpatient-clinics-market

Factors Fuelling Global Market Growth

Growth of the global outpatient clinics market is mainly bound to various macro-economic and micro-economic factors. Prevalence of chronic diseases such as asthma, diabetes, depression and congestive heart failures lead to complex and severe health problems. With the escalating cost of treatment process in various healthcare organizations, patients prefer visiting the outpatient clinics for accessing treatment. Growing concerns regarding the increasing prevalence of cardiovascular diseases such as elevated blood pressure levels, hypertension, coronary heart diseases and cerebrovascular diseases has further led to surge in demand for the outpatient clinics globally.

Demand for quick and effective treatment of cardiovascular diseases will continue to contribute towards the global market growth of outpatient disorders. According to a recently published report by CDC, nearly 610,000 people die of heart attack in the U.S. each year, which is 1 in every 4 deaths. As cardiovascular diseases continue to remain a leading cause of mortality globally, demand for effective and quick treatment process will continue to remain high. These factors are projected to impact the global market growth of outpatient clinics throughout the forecast period.

Request to view Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-5697

Collaborations among the private insurance companies and outpatient clinics will continue to remain a major trend in the global market. Through collaborations the private insurance companies offer payment and services in outpatient clinics. Imposition of regulations such as Health Care and Educational Reconciliation Act and Patient Care Affordable Act provides the U.S. citizens with the public health insurance coverage and offers access to private health insurance services. Moreover, increasing employee benefits such as Employees’ health insurance by the employers is projected to contribute towards the global market growth of outpatient clinics over the forecast period.

However, the global market of outpatient clinics will continue to witness inhibiting growth attributed to various factors. Imposition of strict regulations and limited number of doctors for the treatment of various diseases will remain a key factor inhibiting demand for services offered by outpatient clinics. As the patients are not monitored for a long period of time, risk of addiction to alcohol and drugs is projected to remain high. Moreover, lack of access to counselors in comparison to the residential and inpatient facility is further projected to impede the global market growth of outpatient clinics.

Buy Outpatient Clinics Market Research Report: https://www.futuremarketinsights.com/checkout/5697

Sales to Remain High Through Cardiology Specialty Areas

Prevalence of chronic and cardiovascular disorders is projected to fuel demand for the multi-specialty centers globally. In terms of revenue, the multi-specialty center type segment is projected to witness significant growth, representing more than US$ 8,400 Mn by 2022-end. Moreover, the multi-specialty center type segment is projected to reflect the fastest growth in the global market of outpatient clinics throughout the forecast period.

On the basis of specialty type, the dermatology segment is projected to reflect a significant CAGR through 2022. However, the cardiology specialty areas segment is projected to represent a robust revenue growth, recording more than US$ 3,000 Mn over the forecast period.

Market Players

Major players in the global market of outpatient clinics are Kaiser Permanente Inc., M D Anderson Cancer Center, Mayo Clinic, Memorial Sloan Kettering, University of Maryland Medical Center, DaVita Inc., Cleveland Clinic, Fresenius Medical Care and Johns Hopkins Medicine.